|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.34 USD | +1.27% |
|
+3.58% | -1.39% |
| Market Cap | 4.45B 3.89B 3.62B 3.33B 6.25B 426B 6.41B 42.9B 16.8B 211B 16.72B 16.36B 728B | P/E 2026 * |
66.2x | P/E 2027 * | 33.3x |
|---|---|---|---|---|---|
| Enterprise Value | 3.48B 3.04B 2.83B 2.61B 4.89B 333B 5.01B 33.56B 13.14B 165B 13.08B 12.8B 569B | EV / Sales 2026 * |
2.81x | EV / Sales 2027 * | 2.34x |
| Free-Float |
99.68% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: ACADIA Pharmaceuticals Inc.
| 1 day | +1.27% | ||
| 1 week | +3.58% | ||
| Current month | +4.11% | ||
| 1 month | +4.03% | ||
| 3 months | +16.19% | ||
| 6 months | +2.81% | ||
| Current year | -1.39% |
| 1 week | 24.23 |  | 26.54 |
| 1 month | 24.23 | | 26.54 |
| Current year | 19.89 | | 27.81 |
| 1 year | 19.69 | | 28.35 |
| 3 years | 13.4 | | 32.59 |
| 5 years | 12.24 | | 33.99 |
| 10 years | 12.24 | | 58.72 |
| Manager | Title | Age | Since |
|---|---|---|---|
Catherine Adams
CEO | Chief Executive Officer | 55 | 19/09/2024 |
Mark Schneyer
DFI | Director of Finance/CFO | 52 | 09/09/2021 |
Scott Cenci
CTO | Chief Tech/Sci/R&D Officer | - | 03/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Laura Brege
BRD | Director/Board Member | 68 | 30/04/2008 |
Stephen Biggar
CHM | Chairman | 55 | 09/06/2016 |
Edmund Harrigan
BRD | Director/Board Member | 73 | 24/11/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 26/06/26 | Sell | Controller/Auditor | -11,421 | 0.0067% | ||
| 29/05/26 | Baker Bros. Advisors LP
| Free | Company | 101,260 | 0.0591% | |
| 29/05/26 | Fiscal year | Director | 41,529 | 0.0243% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.27% | +3.58% | +16.45% | -9.30% | 4.45B | |
| +2.61% | +1.91% | +1.70% | +13.91% | 47.88B | |
| -1.60% | -1.29% | +385.56% | +603.70% | 39.09B | |
| -0.98% | +2.68% | +11.10% | +45.34% | 36.75B | |
| +1.90% | +22.79% | +25.18% | +9.47% | 40.55B | |
| +1.47% | +4.90% | +6.48% | +43.52% | 27.96B | |
| -0.94% | -1.23% | - | - | 16.77B | |
| +2.44% | +10.02% | +29.11% | +129.56% | 15.94B | |
| +0.18% | -1.46% | +4.92% | +10.14% | 13.55B | |
| -1.14% | +6.94% | -6.05% | -29.33% | 13.81B | |
| Average | +0.52% | +4.42% | +52.72% | +90.78% | 25.67B | |
| Weighted average by Cap. | +0.62% | +5.01% | +72.02% | +122.04% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.24B 1.08B 1.01B 929M 1.74B 119B 1.79B 11.96B 4.68B 58.81B 4.66B 4.56B 203B | 1.4B 1.22B 1.14B 1.05B 1.97B 134B 2.02B 13.49B 5.28B 66.35B 5.26B 5.14B 229B |
| Net income | 67.44M 58.85M 54.87M 50.48M 94.69M 6.45B 97.07M 650M 254M 3.19B 253M 248M 11.02B | 142M 124M 115M 106M 199M 13.57B 204M 1.37B 535M 6.72B 533M 521M 23.18B |
| Net Debt | -970M -846M -789M -726M -1.36B -92.76B -1.4B -9.34B -3.66B -45.95B -3.64B -3.56B -158B | -1.18B -1.03B -963M -886M -1.66B -113B -1.7B -11.4B -4.46B -56.05B -4.44B -4.35B -193B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/07/26 | US$26.34 | +1.27% | 1,731,438 |
| 28/07/26 | US$26.01 | +2.44% | 940,899 |
| 27/07/26 | US$25.39 | +2.21% | 1,399,666 |
| 24/07/26 | US$24.84 | +0.04% | 1,046,976 |
| 23/07/26 | US$24.83 | -0.52% | 1,272,018 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ACAD Stock
Select your edition
All financial news and data tailored to specific country editions
